Lewis-Sumner syndrome associated with infliximab therapy in ulcerative colitis

Neurol Sci. 2016 Jun;37(6):1005-8. doi: 10.1007/s10072-016-2490-4. Epub 2016 Feb 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Adult
  • Colitis, Ulcerative / drug therapy
  • Gastrointestinal Agents / adverse effects*
  • Humans
  • Infliximab / adverse effects*
  • Male
  • Neural Conduction / drug effects
  • Neural Conduction / physiology
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / chemically induced*
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / diagnosis
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / physiopathology
  • Reaction Time / physiology
  • Tumor Necrosis Factor-alpha / immunology
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab